• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How to monitor safety and efficacy of biologic treatment in rare, therapy-refractory immune-mediated inflammatory diseases?

作者信息

Musters Anne, Tas Sander W

机构信息

Amsterdam Rheumatology and Immunology Center, Academic Medical Center (AMC)/University of Amsterdam, The Netherlands.

出版信息

Rheumatology (Oxford). 2018 Apr 1;57(4):591-593. doi: 10.1093/rheumatology/kex016.

DOI:10.1093/rheumatology/kex016
PMID:28339729
Abstract
摘要

相似文献

1
How to monitor safety and efficacy of biologic treatment in rare, therapy-refractory immune-mediated inflammatory diseases?如何监测罕见的、治疗难治性免疫介导炎症性疾病中生物治疗的安全性和有效性？
Rheumatology (Oxford). 2018 Apr 1;57(4):591-593. doi: 10.1093/rheumatology/kex016.
2
Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory Conditions.用于治疗免疫介导炎症性疾病的抗白细胞介素-23和抗白细胞介素-17生物制剂
Clin Pharmacol Ther. 2018 Jan;103(1):88-101. doi: 10.1002/cpt.893. Epub 2017 Oct 19.
3
The Use of Biologic Modifiers as a Bridge to Hematopoietic Cell Transplantation in Primary Immune Regulatory Disorders.原发性免疫调节障碍中生物调节剂作为造血细胞移植桥接的应用。
Front Immunol. 2021 Jun 24;12:692219. doi: 10.3389/fimmu.2021.692219. eCollection 2021.
4
Efficacy and safety of biologicals against immune-mediated diseases: do benefits outweigh risks?生物制剂治疗免疫介导疾病的疗效与安全性：益处是否大于风险？
Drugs Today (Barc). 2010 Feb;46(2):119-36. doi: 10.1358/dot.2010.46.2.1452078.
5
Treatment of allergic diseases with pyromen.用焦煤油治疗过敏性疾病。
Eye Ear Nose Throat Mon. 1953 May;32(5):261-2.
6
The value of piromen in the treatment of allergic disorders.吡罗昔康在过敏性疾病治疗中的价值。 （注：你原文中的“piromen”可能有误，常见的是“piroxicam”即吡罗昔康，这里按照正确药物名翻译了，若原文无误，请忽略此注释）
Ann Allergy. 1953 May-Jun;11(3):344-53.
7
Biologic therapy for rheumatoid arthritis in developing countries--a place for non-TNF inhibitors as first-line treatment?发展中国家类风湿关节炎的生物治疗——非肿瘤坏死因子抑制剂作为一线治疗的地位？
Rheumatology (Oxford). 2015 Feb;54(2):208-9. doi: 10.1093/rheumatology/keu040. Epub 2014 Mar 31.
8
Biological preparations with clinical efficacy in the prevention and therapy of allergic syndromes.在预防和治疗过敏综合征方面具有临床疗效的生物制剂。
Arch Roum Pathol Exp Microbiol. 1990 Jan-Mar;49(1):17-30.
9
Novel diagnostic approaches and cost-benefit balance of treatment of immune-mediated and rare disease in the era of biologic drugs: lessons from the 15th Turin Congress on Immune Pathology and Orphan Disease.生物药物时代免疫介导性和罕见病的新型诊断方法及治疗的成本效益平衡：来自第15届都灵免疫病理学与罕见病大会的经验教训
Autoimmun Rev. 2013 Jun;12(8):793-5. doi: 10.1016/j.autrev.2012.11.002. Epub 2012 Dec 4.
10
Introduction.引言。
Dermatol Ther. 2009 Jan-Feb;22(1):1. doi: 10.1111/j.1529-8019.2008.01211.x.

引用本文的文献

1
Spinning straw into gold: description of a disruptive rheumatology research platform inspired by the COVID-19 pandemic.点石成金：受 COVID-19 大流行启发的颠覆性风湿病学研究平台描述。
Arthritis Res Ther. 2021 Aug 5;23(1):207. doi: 10.1186/s13075-021-02574-z.
2
Undifferentiated connective tissue disease: state of the art on clinical practice guidelines.未分化结缔组织病：临床实践指南的最新进展
RMD Open. 2019 Feb 26;4(Suppl 1):e000786. doi: 10.1136/rmdopen-2018-000786. eCollection 2018.
3
Mixed connective tissue disease: state of the art on clinical practice guidelines.
混合性结缔组织病：临床实践指南的最新进展
RMD Open. 2018 Oct 18;4(Suppl 1):e000783. doi: 10.1136/rmdopen-2018-000783. eCollection 2018.